Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Alzheimer's disease: Time to reassess research and clinical priorities

Wiatrak B, Szeląg A.

Adv Clin Exp Med. 2026 Mar;35(3):397-401. doi: 10.17219/acem/217199.

Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis

Malek-Ahmadi M, Sharma S, Stipho F, Denkinger M, Singh A, Brum WS, Ashton NJ.

JAMA Neurol. 2026 Jan 1;83(1):13-19. doi: 10.1001/jamaneurol.2025.4721.

Alzheimer's disease

Serrano-Pozo A, Escott-Price V, Grinberg LT, Pascoal T, Suárez-Calvet M, Dubois B, Sperling RA.

Lancet. 2026 May 30;407(10544):2241-2262. doi: 10.1016/S0140-6736(26)00198-4.

Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias

Zetterberg H, Bendlin BB.

Nature. 2026 Feb;650(8100):49-59. doi: 10.1038/s41586-025-10018-w. Epub 2026 Feb 4.

Evaluation of Polygenic Risk Scores for a Possible Genetic Basis of the Inverse Association Between Cancer and Cognitive Decline

Graff RE, Chen DM, Swinnerton KN, Ackley SF, Ospina-Romero M, Zimmerman SC, Wang J, Buto P, Nierenberg JL, Elahi FM, Lu KP, Witte JS, Glymour MM.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):235-243. doi: 10.1097/WAD.0000000000000696. Epub 2025 Oct 23.

The effect of Alzheimer's disease genetic factors on limbic white matter microstructure

Lorenz A, Sathe A, Zaras D, Yang Y, Durant A, Kim ME, Gao C, Newlin NR, Ramadass K, Kanakaraj P, Khairi NM, Li Z, Yao T, Huo Y, Dumitrescu L, Shashikumar N, Pechman KR, Jackson TB, Workmeister AW, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Habes M, Wang D, Tosun D, Toga AW, Thompson PM, Mormino EC, Zhang P, Schilling K; Alzheimer's Disease Neuroimaging Initiative (ADNI)The BIOCARD Study TeamThe Alzheimer's Disease Sequencing Project (ADSP); Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Bendlin B, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB.

Alzheimers Dement. 2025 Apr;21(4):e70130. doi: 10.1002/alz.70130.

Synthesizing individualized aging brains in health and disease with generative models and parallel transport

Fu J, Zheng Y, Dey N, Ferreira D, Moreno R.

Med Image Anal. 2025 Oct;105:103669. doi: 10.1016/j.media.2025.103669. Epub 2025 Jun 16.

Clinical Practice Recommendations of the Swiss Society for Neuroradiology: Neuroimaging Standards for Enrollment and Disease Monitoring in Anti-Amyloid Immunotherapies

Wiest R, Radojewski P, Lieb JM, Psychogios M, Benzinger TLS, Franceschi AM, Wanke I, Draganski B, Kurz FT, Lövblad KO.

Neurodegener Dis. 2026;26(2):77-88. doi: 10.1159/000549521. Epub 2025 Nov 12.

Five-Year Cognitive Trajectories in Individuals with Mild Cognitive Impairment and Mild Dementia: Associations with Attendance in a Multimodal Day-Care Program

Nemoto M, Nemoto K, Ota M, Sasai H, Midorikawa H, Sekine A, Kitabatake A, Arai T.

Dement Geriatr Cogn Disord. 2026;55(3):223-232. doi: 10.1159/000548680. Epub 2025 Sep 29.

Synaptosomal-Associated Protein 25 kDA (SNAP-25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring

Wolner SH, Gleerup HS, Musaeus CS, Høgh P, Ashton NJ, Brinkmalm A, Nilsson J, Grötschel L, Zetterberg H, Blennow K, Hasselbalch SG, Walls AB, Simonsen AH.

Synapse. 2025 Mar;79(2):e70010. doi: 10.1002/syn.70010.

A cytometric bead array for the measurement of plasma biomarker levels in patients with Alzheimer's disease

Liu Y, Liu X, Che P, Wang Y, Piao Z, Wang Y, Cai L, Xing M, Xu Y, Sun W, Wang Y, Zhang N.

Sci Rep. 2025 Mar 21;15(1):9767. doi: 10.1038/s41598-024-83919-x.

Diagnostic Performance of Eight Blood-based Biomarkers in a Well-characterized Korean Cohort of Preclinical Alzheimer's Disease

Chae H, Kim H, Kim YJ, Ji H, Oh EJ, Yang DW.

Ann Lab Med. 2025 Jul 1;45(4):428-436. doi: 10.3343/alm.2024.0498. Epub 2025 May 12.

Relationship between cerebrospinal fluid catecholamines levels and biomarkers of Alzheimer's disease, inflammation and neuronal injury

Portela Moreira I, Serrão P, Sequeira L, Sá MJ, Vieira-Coelho MA, Guimarães J.

Neurol Res. 2026 Jun;48(6):732-742. doi: 10.1080/01616412.2025.2542944. Epub 2025 Aug 3.

The Effect of Bacterial Composition Shifts in the Oral Microbiota on Alzheimer's Disease

Moghadam MT, Mojtahedi A, Bakhshayesh B, Babakhani S, Ajorloo P, Shariati A, Mirzaei M, Heidarzadeh S, Jazi FM.

Curr Mol Med. 2024;24(2):167-181. doi: 10.2174/1566524023666220819140748.

Signalling Pathways Involved in Microglial Activation in Alzheimer's Disease and Potential Neuroprotective Role of Phytoconstituents

Ali MU, Anwar L, Ali MH, Iqubal MK, Iqubal A, Baboota S, Ali J.

CNS Neurol Disord Drug Targets. 2024;23(7):819-840. doi: 10.2174/1871527322666221223091529.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias